BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sundaram V, Jalan R, Shah P, Singal AK, Patel AA, Wu T, Noureddin M, Mahmud N, Wong RJ. Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A Growing and Aging Cohort With Rising Mortality. Hepatology 2021;73:1932-44. [DOI: 10.1002/hep.31566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Sundaram V. Characterizing bacterial infections in acute-on-chronic liver failure among patients with cirrhosis from nonalcoholic steatohepatitis. J Hepatol 2021;75:1008-9. [PMID: 33862038 DOI: 10.1016/j.jhep.2021.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sundaram V, Jalan R. Waitlist Priority for Patients with Acute-on-Chronic Liver Failure: Not Just Horseplay. Liver Transpl 2021. [PMID: 34623745 DOI: 10.1002/lt.26330] [Reference Citation Analysis]
3 Singal AK, Wong RJ, Jalan R, Asrani S, Kuo YF. Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant. Clin Transplant 2021;35:e14479. [PMID: 34510550 DOI: 10.1111/ctr.14479] [Reference Citation Analysis]
4 Cotter TG, Sundaram V. Living Donor Liver Transplantation in Acute-on-Chronic Liver Failure: Encouraging Outcomes But With Important Caveats. Liver Transpl 2021;27:1532-4. [PMID: 34120409 DOI: 10.1002/lt.26208] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhou Z, Lai P, Zhang S, Wang Y, Qu N, Lu D, Gao L, Xu L, Yang Y, Zhang T, Sun X, Zheng X, Liu Y, Liang H, Chen S. The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver Disease. Biomed Res Int 2021;2021:6612477. [PMID: 33860040 DOI: 10.1155/2021/6612477] [Reference Citation Analysis]
6 Vipani A, Lindenmeyer CC, Sundaram V. Treatment of Severe Acute on Chronic Liver Failure: Management of Organ Failures, Investigational Therapeutics, and the Role of Liver Transplantation. J Clin Gastroenterol 2021;55:667-76. [PMID: 34028394 DOI: 10.1097/MCG.0000000000001568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Maruyama H, Shiina S. Connection between HPS and ACLF: a solution of chaos? Hepatol Int 2021;15:1049-52. [PMID: 34606063 DOI: 10.1007/s12072-021-10255-x] [Reference Citation Analysis]
8 Polyak A, Kuo A, Sundaram V. Evolution of liver transplant organ allocation policy: Current limitations and future directions. World J Hepatol 2021; 13(8): 830-839 [PMID: 34552690 DOI: 10.4254/wjh.v13.i8.830] [Reference Citation Analysis]
9 Singal AK, Arsalan A, Dunn W, Arab JP, Wong RJ, Kuo YF, Kamath PS, Shah VH. Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics. Aliment Pharmacol Ther 2021;54:451-61. [PMID: 34247424 DOI: 10.1111/apt.16461] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]